Overview

Imaging assesses marrow involvement splenic size and complications of hematologic disease. Modalities include MRI CT ultrasound and nuclear medicine. Imaging guides diagnosis staging and response assessment.

Marrow Imaging

MRI detects marrow infiltration edema and focal lesions in hematologic malignancies. Whole body MRI and PET CT assess disease burden and treatment response. Quantitative metrics support prognostication.

Splenic and Vascular Assessment

Ultrasound and CT evaluate splenomegaly portal hypertension and vascular complications. Imaging guides interventions and monitoring of therapy related effects. Correlation with laboratory data informs management.

Post Treatment Surveillance

Imaging monitors for relapse complications and treatment toxicity in hematologic patients. Choice of modality depends on disease type and clinical question. Multidisciplinary care integrates imaging into long term follow up.